Indoco Remedies Ltd

NSE: INDOCO · BSE: 532612 · Pharmaceuticals & Biotechnology · 11 announcements

Share price: ₹254.46
Market cap: ₹2,349 Cr
Revenue (annual): ₹1,845 Cr
Net profit (annual): ₹-95.14 Cr
P/E (TTM): 417.2×Sector 50.4×
Promoter holding: 58.86%+0.00% QoQ
FII holding: 1.27%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Promoter Buying 3 Financial Results 2 Earnings Call 2 Other Announcement 1 Merger & Restructuring 1 Business Update 1 Annual General Meeting 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

2 announcements with these filters

4 Aug 2026 11:59 IST BSE

Earnings Call

Indoco Remedies Investor Presentation: Key Takeaways

Indoco Remedies reported Q1FY27 consolidated revenue of INR 4,662 million, up 8.2% YoY. Management focuses on debt reduction, operational efficiency, and scaling domestic mid-sized brands while awaiting USFDA audits.

Call: Guides 11% growth

Open call summary → Read the filing ↗

11 May 2026 11:08 IST BSE

Earnings Call

Indoco Remedies Earnings Call: Key Takeaways

Indoco Remedies reported recovery in Q4FY26, driven by 94.6% growth in international formulations. Consolidated revenue reached ₹4,559 million with EBITDA margins improving to 10.9%.

Open call summary → Read the filing ↗